NL159660B - PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION THAT ANTAGONIZES DOPAMINE AND DOPAMINERGIC COMPOUNDS, AS WELL AS PROCEDURE FOR PREPARING AN N- (TERT AMINO ALKYL) 2-ALKOXY-4-AMINO-5-HALOGENESBALOGEN. - Google Patents

PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION THAT ANTAGONIZES DOPAMINE AND DOPAMINERGIC COMPOUNDS, AS WELL AS PROCEDURE FOR PREPARING AN N- (TERT AMINO ALKYL) 2-ALKOXY-4-AMINO-5-HALOGENESBALOGEN.

Info

Publication number
NL159660B
NL159660B NL7503417.A NL7503417A NL159660B NL 159660 B NL159660 B NL 159660B NL 7503417 A NL7503417 A NL 7503417A NL 159660 B NL159660 B NL 159660B
Authority
NL
Netherlands
Prior art keywords
preparing
procedure
amino
halogenesbalogen
alkoxy
Prior art date
Application number
NL7503417.A
Other languages
Dutch (nl)
Other versions
NL7503417A (en
Original Assignee
Anphar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB12572/74A external-priority patent/GB1507462A/en
Application filed by Anphar Sa filed Critical Anphar Sa
Publication of NL7503417A publication Critical patent/NL7503417A/en
Publication of NL159660B publication Critical patent/NL159660B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
NL7503417.A 1974-03-21 1975-03-21 PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION THAT ANTAGONIZES DOPAMINE AND DOPAMINERGIC COMPOUNDS, AS WELL AS PROCEDURE FOR PREPARING AN N- (TERT AMINO ALKYL) 2-ALKOXY-4-AMINO-5-HALOGENESBALOGEN. NL159660B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB12572/74A GB1507462A (en) 1974-03-21 1974-03-21 N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
GB3540274 1974-08-12

Publications (2)

Publication Number Publication Date
NL7503417A NL7503417A (en) 1975-09-23
NL159660B true NL159660B (en) 1979-03-15

Family

ID=26249107

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7503417.A NL159660B (en) 1974-03-21 1975-03-21 PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION THAT ANTAGONIZES DOPAMINE AND DOPAMINERGIC COMPOUNDS, AS WELL AS PROCEDURE FOR PREPARING AN N- (TERT AMINO ALKYL) 2-ALKOXY-4-AMINO-5-HALOGENESBALOGEN.

Country Status (11)

Country Link
JP (1) JPS584019B2 (en)
AR (1) AR216043A1 (en)
CH (1) CH602641A5 (en)
DK (1) DK147854C (en)
ES (5) ES435753A1 (en)
FI (1) FI60200C (en)
FR (1) FR2264530A1 (en)
KE (1) KE2900A (en)
NL (1) NL159660B (en)
NO (1) NO144108C (en)
SE (1) SE427750B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1513631A (en) * 1976-02-17 1978-06-07 Gallardo Antonio Sa Piperidine derivatives
GB1561023A (en) * 1977-04-22 1980-02-13 Beecham Group Ltd 2-methoxy - 5 - chloro aniline derivatives
FR2446274A1 (en) * 1979-01-15 1980-08-08 Delalande Sa 5-Acetoxy:methyl and 5-chloro:methyl 2-methoxy benzamide(s) - and related cpds. have neuroleptic activity and are used for psychic disorders
EP0343307A1 (en) * 1988-05-26 1989-11-29 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. 4-Piperidinealkanamine derivatives
FR2674849B1 (en) * 1991-04-02 1994-12-23 Logeais Labor Jacques NOVEL N-CYCLOHEXYL BENZAMIDES OR THIOBENZAMIDES DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS.
FR2766484B1 (en) * 1997-07-25 1999-09-17 Logeais Labor Jacques NOVEL STIMULATING BENZAMIDE DERIVATIVES OF HIGH AND LOW GASTROINTESTINAL MOTORITY
FR2766486B1 (en) * 1997-07-25 1999-09-17 Logeais Labor Jacques HIGH AND LOW GASTROINTESTINAL MOTOR STIMULATING BENZAMIDE CYCLOALKYLES
ATE445612T1 (en) * 2005-06-02 2009-10-15 Hoffmann La Roche PIPERIDINE-4-YL AMIDE DERIVATIVES AND THEIR USE AS SUBTYPE 5 SST RECEPTOR ANTAGONISTS
KR100976063B1 (en) * 2007-03-16 2010-08-17 동아제약주식회사 Novel benzamide derivatives and process for the preparation thereof
JP6145109B2 (en) * 2011-11-29 2017-07-05 ビボゾン インコーポレイテッド Novel benzamide derivatives and uses thereof

Also Published As

Publication number Publication date
FI750825A (en) 1975-09-22
JPS50129573A (en) 1975-10-13
SE427750B (en) 1983-05-02
ES435754A1 (en) 1977-04-01
ES435753A1 (en) 1977-04-01
AR216043A1 (en) 1979-11-30
DK147854C (en) 1985-07-22
KE2900A (en) 1978-12-01
SE7503196L (en) 1975-09-22
FR2264530B1 (en) 1978-11-10
ES435755A1 (en) 1977-04-01
NO144108C (en) 1981-06-24
CH602641A5 (en) 1978-07-31
NO144108B (en) 1981-03-16
JPS584019B2 (en) 1983-01-24
FI60200C (en) 1981-12-10
ES435756A1 (en) 1977-04-01
FI60200B (en) 1981-08-31
FR2264530A1 (en) 1975-10-17
DK147854B (en) 1984-12-24
DK117675A (en) 1975-09-22
NO750957L (en) 1975-09-23
NL7503417A (en) 1975-09-23
ES435757A1 (en) 1977-04-01

Similar Documents

Publication Publication Date Title
NL187161B (en) A method for the preparation of an olefin derivative of an amino acid, and a method for the preparation of a pharmaceutical composition containing this compound, and the pharmaceutical composition formed.
NL178688C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AS A MUSCLE RELAXAN AND SUITABLE BIS-ISOQUINOLINIUM COMPOUNDS.
NL7602776A (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL FORMULATION WITH RETARDE EFFECT.
NL171072C (en) PROCESS FOR PREPARING A FREE-LIQUID LACTULOSE-CONTAINING POWDER
NL7606172A (en) PROCESS FOR PREPARING N-SUBSTITUTED 2-METHOXYBENZE SULPHONAMIDES, PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION USING THIS AS WELL AS A PREPARATION SUCHED.
NL187228C (en) METHOD FOR PREPARING A GEL-BASED CARRIER
NL184558C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING A MOTHERNESS CALCALIDE; PHARMACEUTICAL OBJECT.
NL7512266A (en) PROCEDURE FOR PREPARING A SHAMPOO.
NL7607902A (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION.
NL182311C (en) PROCESS FOR THE PREPARATION OF A HELMINTHICIDE PREPARATION AND PROCESS FOR PREPARING A SUBSTITUTED N- (4- (ARYLMETHYL) PHENYL) -2-HYDROXYBENZAMIDE.
NL7601051A (en) PROCEDURE FOR PREPARING AN ORAL ROTARY CONTRAST AGENT.
NL7611569A (en) PROCEDURE FOR PREPARING A PEPTIDE.
NL159660B (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION THAT ANTAGONIZES DOPAMINE AND DOPAMINERGIC COMPOUNDS, AS WELL AS PROCEDURE FOR PREPARING AN N- (TERT AMINO ALKYL) 2-ALKOXY-4-AMINO-5-HALOGENESBALOGEN.
NL7607168A (en) PROCESS FOR PREPARING AN AMPHOTERIC POLYMER COMPOSITION.
NL7607011A (en) METHOD FOR PREPARING BICYCLOHEPEN COMPOUNDS, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION USING THEREOF AND AN SUCH PREPARATION.
NL7606824A (en) PROCESS FOR PREPARING AN ORAL PREPARATION.
NL7603043A (en) PROCEDURE FOR PREPARING PROSTAGLANDIN CONTAINING FREEZED POWDER AND PROCEDURE FOR PREPARING A MEDICINAL PRODUCT WITH PROSTAGLANDIN ACTION.
NL7605636A (en) PROCEDURE FOR PREPARING AN N- (AMINO-ALKYL) PIPERAZINE.
NL163780C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION, PRODUCED PREPARED PREPARATION THEREOF, AND METHOD
NL7509548A (en) AMINE COMPOUNDS AND PHARMACEUTICAL PREPARATION AND PROCEDURE FOR PREPARING THEM.
NL7510120A (en) PROCEDURE FOR PREPARING A VACCINE AGAINST TREASURE DISORDERS.
NL187267C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, AND PROCESS FOR PREPARING AN N-ARYL-N- (4-PIPERIDINYL) ACETAMIDE DERIVATIVE.
NL176362C (en) PROCESS FOR PREPARING A 4- (2-ACYLOXY-3-AMINOPROPOXY) INDOLE AND PHARMACEUTICAL PREPARATION CONTAINING THIS COMPOUND
NL7509469A (en) PROCESS FOR PREPARING AN ORAL PREPARATION.
NL7506210A (en) METHOD OF PREPARING A 1H-TETRA-SOLE DERIVATIVE AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.

Legal Events

Date Code Title Description
TNT Modifications of names of proprietors of patents or applicants of examined patent applications

Owner name: FORDONAL, S.A.

NL80 Information provided on patent owner name for an already discontinued patent

Owner name: ANPHAR

V4 Discontinued because of reaching the maximum lifetime of a patent